1-s2.0-S0955395920301614-main.pdf (657.81 kB)
Download file

The effects of the iPlayClean education programme on doping attitudes and susceptibility to use banned substances among high-level adolescent athletes from the UK: a cluster-randomised control trial

Download (657.81 kB)
journal contribution
posted on 18.06.2020, 14:05 by Adam R. Nicholls, David Morley, Mark A. Thompson, Chao Huang, Grant Abt, Martyn Rothwell, Ed CopeEd Cope, Nikos Ntoumanis
Background This study examined the effects of the iPlayClean anti-doping intervention on attitudes towards doping and susceptibility, and whether delivery mode affected the results.

Methods A total of 1081 high-level UK athletes (14–18 years old, 904 males, 177 females) were cluster-randomised to the control (11 teams/organisations/schools, 314 athletes), face-to-face group presentation (8 teams/organisations/schools, 254 athletes), online (11 teams/organisations/schools, 251 athletes), or face-to-face presentation with online access (5 teams/organisations/schools, 262 athletes).

Results Compared to the control group, all modes of the iPlayClean anti-doping education programme reduced favourable attitudes towards doping immediately after the intervention, which was sustained across all intervention groups 8 weeks later. All delivery modes impacted doping susceptibility immediately after the intervention, in comparison to the control group, but the effects were only sustained for the face-to-face presentation group.

Conclusion Contrary to findings within previous anti-doping interventions, we have shown that doping attitudes can be changed and that the results can be sustained across all modes of delivery, 8 weeks later. Research is required to assess for how long these changes are sustained, and how often anti-doping education should be delivered to high-level athletes to reinforce clean play values.

Funding

International Olympic Committee [grant number 0363-400, 2015].

History

School

  • Sport, Exercise and Health Sciences

Published in

International Journal of Drug Policy

Volume

82

Publisher

Elsevier B.V.

Version

VoR (Version of Record)

Rights holder

© The Authors

Publisher statement

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).

Acceptance date

05/06/2020

Publication date

2020-06-17

Copyright date

2020

ISSN

0955-3959

Language

en

Depositor

Dr Ed Cope. Deposit date: 17 June 2020

Article number

102820

Usage metrics

Categories

Exports